GlassScriptPhysician profile
David F Castillo
NPI 1730447830
$3,008.52
in general payments reported to CMS, 2019-2025
15 companies · $412 in 2025
The $412 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $610 · 2022: $881 · 2023: $600 · 2024: $505 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,517.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $800.56 | 2021-2025 | Cardiomems, Mitraclip, Absolute Pro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $671.37 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $564.14 | 2021-2025 | Watchman, Lux-Dx Insertable Cardiac Monitor, Accolade Sr |
| Medtronic, INC. | $454.86 | 2021-2022 | |
| Edwards Lifesciences Corporation | $114.14 | 2023 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Actelion Pharmaceuticals US, INC. | $112.96 | 2024 | Uptravi, Opsumit |
| Novartis Pharmaceuticals Corporation | $80.78 | 2023-2024 | |
| Janssen Biotech, INC. | $56.02 | 2022 | |
| Acacia Pharma INC | $30.82 | 2022 | |
| Abiomed | $28.27 | 2023 | Impella |
| Inspire Medical Systems, INC. | $23.83 | 2024 | Inspire |
| Altathera Pharmaceuticals LLC | $22.99 | 2024 | Sotalol Hydrochloride |
| Zoll Respicardia, INC. | $20.23 | 2024 | Remede System |
| E.R. Squibb & Sons, L.L.C. | $14.86 | 2025 | Eliquis |
| Tactile Systems Technology INC | $12.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Castillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.